WallStSmart

Corteva Inc (CTVA)vsNexentis Technologies Inc. (NXTS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Corteva Inc generates 8559230% more annual revenue ($17.89B vs $209,000). CTVA leads profitability with a 6.5% profit margin vs 0.0%. CTVA earns a higher WallStSmart Score of 64/100 (C+).

CTVA

Buy

64

out of 100

Grade: C+

Growth: 4.7Profit: 5.5Value: 4.0Quality: 6.0
Piotroski: 4/9Altman Z: 1.49

NXTS

Avoid

26

out of 100

Grade: F

Growth: 3.7Profit: 3.0Value: 5.0Quality: 7.0
Piotroski: 4/9Altman Z: -1.17
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CTVASignificantly Overvalued (-73.4%)

Margin of Safety

-73.4%

Fair Value

$44.32

Current Price

$77.46

$33.14 premium

UndervaluedFair: $44.32Overvalued

Intrinsic value data unavailable for NXTS.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CTVA4 strengths · Avg: 8.5/10
Market CapQuality
$50.64B9/10

Large-cap with strong market position

Debt/EquityHealth
0.149/10

Conservative balance sheet, low leverage

Price/BookValuation
2.1x8/10

Reasonable price relative to book value

Operating MarginProfitability
23.7%8/10

Strong operational efficiency at 23.7%

NXTS2 strengths · Avg: 10.0/10
Price/BookValuation
0.3x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.0410/10

Conservative balance sheet, low leverage

Areas to Watch

CTVA4 concerns · Avg: 2.5/10
Return on EquityProfitability
4.8%3/10

ROE of 4.8% — below average capital efficiency

Profit MarginProfitability
6.5%3/10

6.5% margin — thin

P/E RatioValuation
40.9x2/10

Premium valuation, high expectations priced in

Free Cash FlowQuality
$-2.97B2/10

Negative free cash flow — burning cash

NXTS4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$4.24M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Operating MarginProfitability
0.0%3/10

Operating margin of 0.0%

Comparative Analysis Report

WallStSmart Research

Bull Case : CTVA

The strongest argument for CTVA centers on Market Cap, Debt/Equity, Price/Book. Revenue growth of 11.0% demonstrates continued momentum. PEG of 1.27 suggests the stock is reasonably priced for its growth.

Bull Case : NXTS

The strongest argument for NXTS centers on Price/Book, Debt/Equity.

Bear Case : CTVA

The primary concerns for CTVA are Return on Equity, Profit Margin, P/E Ratio. A P/E of 40.9x leaves little room for execution misses.

Bear Case : NXTS

The primary concerns for NXTS are EPS Growth, Market Cap, Profit Margin.

Key Dynamics to Monitor

NXTS carries more volatility with a beta of 1.74 — expect wider price swings.

CTVA is growing revenue faster at 11.0% — sustainability is the question.

NXTS generates stronger free cash flow (-1M), providing more financial flexibility.

Monitor AGRICULTURAL INPUTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CTVA scores higher overall (64/100 vs 26/100) and 11.0% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Corteva Inc

BASIC MATERIALS · AGRICULTURAL INPUTS · USA

Corteva, Inc. (also known as Corteva Agriscience) is a major American agricultural chemical and seed company that was the agricultural unit of DowDuPont prior to being spun off as an independent public company.

Visit Website →

Nexentis Technologies Inc.

BASIC MATERIALS · AGRICULTURAL INPUTS · USA

Nexentis Technologies Inc. develops and operates an AI and data-driven computational biotech platform. The company is headquartered in Hod HaSharon, Israel.

Want to dig deeper into these stocks?